Subscribe To
Immuneering to present preclinical data on imm-1-104 and imm-6-415 at aacr-nci-eortc international conference on molecular targets and cancer therapeutics
CAMBRIDGE, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company developing medicines for...
October 4, 2023, 4:05 pm
Omega therapeutics to present new preclinical data on otx-2101 at the 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics
CAMBRIDGE, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pion...
October 4, 2023, 4:00 pm
Black diamond therapeutics to present preclinical and clinical data at the aacr-nci-eortc international conference on molecular targets and cancer therapeutics
CAMBRIDGE, Mass. and NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology ...
October 4, 2023, 12:14 pm
Kura oncology announces three presentations at aacr-nci-eortc international conference on molecular targets and cancer therapeutics
– Presentations to highlight preclinical data supporting combination of KO-2806 with targeted therapies, including TKIs, KRASG12C inhibitors and KRA...
October 4, 2023, 11:30 am
Beyond cancer™ selected to present proffered posters discussing data from the uno therapy program at the 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics
GARDEN CITY, N.Y. and HAMILTON, Bermuda, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., an affiliate of Beyond Air, Inc. (NASDAQ: XAIR) that i...
October 4, 2023, 7:30 am
Structure therapeutics: tipping the scales in obesity management
Structure Therapeutics' oral small molecule GLP-1, GSBR-1290, has shown promising results in Phase 1b s...
October 3, 2023, 11:28 pm
Chipotle is testing automation for burrito bowls, salads
Fast-casual-dining chain Chipotle is also testing out robots to help make tortillas and guacamole....
October 3, 2023, 9:06 am
Acumen pharmaceuticals: novel alzheimer's molecule with positive early data
Acumen Pharmaceuticals is developing a monoclonal antibody, ACU193, that targets Amyloid beta oligomers (AβOs) in Alzheimer's disease. AβOs are smal...
October 3, 2023, 5:15 am
Angle hails the latest breast cancer study
ANGLE PLC (AIM:AGL, OTCQX:ANPCY), the liquid biopsy and cancer diagnostics specialist, has hailed a study that could change the way doctors monitor a...
October 3, 2023, 2:46 am
The cost to borrow t2 (ttoo) stock is up 130% in just 10 days
Shares of T2 Biosystems (NASDAQ: TTOO ) are up by over 20% today on the heels of receiving U.S. Food and Drug Administration (FDA) 510(k) clearance fo...
September 29, 2023, 12:18 pm
Schrodinger: leading the ai healthcare revolution
Schrödinger is a leading AI drug discovery company with a comprehensive platform used by researchers and scientists worldwide. The company's flagship...
September 29, 2023, 3:49 am
Aclaris therapeutics: the many lives of this biopharmaceutical developer
Aclaris Therapeutics is a developer of kinome-based medicines for immune-inflammatory and oncology indications. The company's platform, KINect, helps ...
September 28, 2023, 7:18 am
Matinas biopharma to present at two investment conferences in october 2023
BEDMINSTER, N.J., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on re...
September 28, 2023, 7:00 am
Gain therapeutics to participate at cantor fitzgerald global healthcare conference 2023
BETHESDA, Md., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (the “Company”), a biotechnology company leading the disc...
September 25, 2023, 4:05 pm
4d molecular therapeutics: some failures, a few key successes
4D molecular Therapeutics, Inc. has faced setbacks, with the FDA placing a clinical hold on its Fabry D...
September 25, 2023, 12:19 pm
Novo nordisk announces ai collaboration with valo health for cardiometabolic treatments
Novo Nordisk (NYSE:NVO) has announced a collaboration with Valo Health to discover and develop novel treatments for cardiometabolic using Valo's artif...
September 25, 2023, 9:51 am
Matinas biopharma announces notification of nyse american continued listing deficiency
BEDMINSTER, N.J., Sept. 22, 2023 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on r...
September 22, 2023, 9:25 pm
Protagonist therapeutics: there are reasons behind johnson & johnson's optimism
Protagonist Therapeutics, Inc.'s oral IL-23 drug for psoriasis, JNJ-2113, must show non-inferior efficacy to Johnson & Johnson's injectable Tremfya be...
September 22, 2023, 3:35 pm
moleculin (mbrx) posts update from lung cancer study, stock up
moleculin (MBRX) completes enrollment in the phase II portion of the development program for its lead c...
September 22, 2023, 9:01 am
Brodsky & smith shareholder update: notifying investors of the following investigations: splunk, inc. (nasdaq – splk), applied molecular transport inc. (nasdaq – amti), nextgen healthcare, inc. (nasda
BALA CYNWYD, Pa., Sept. 21, 2023 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to...
September 21, 2023, 8:57 pm